Overview

Multiparametric Imaging in Multiple Myeloma

Status:
Completed

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

Patients with Multiple Myeloma will undergo single timepoint Positron Emission Tomography imaging with intravenously injected C11 Methionine to detect viable lesions.

Phase:

Phase 1

Details

Lead Sponsor:

Yingbing Wang

Treatments:

Carbon-11 methionine